Characterization of candidate histone methyltransferases
候选组蛋白甲基转移酶的表征
基本信息
- 批准号:7592813
- 负责人:
- 金额:$ 33.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AntibodiesAsthmaB-LymphocytesBaculovirusesBindingBiochemicalBiological ProcessChimeric ProteinsChronic Lymphocytic LeukemiaCo-ImmunoprecipitationsDefectDevelopmentDiseaseGene FamilyGenesGenetic TranscriptionGoalsHistonesHumanKnock-outKnockout MiceLaboratoriesLinkLocalizedLysineMalignant NeoplasmsMethylationModelingMouse StrainsMusPlantsProcessProtein BindingProteinsQuantitative Trait LociRNA SplicingRecombinantsRoleRole playing therapyStructureTissuesTranscriptYeastsZinc Fingersatopybasehistone methyltransferasehomeodomainhuman diseaseinterestmembermouse modelresearch studyyeast two hybrid system
项目摘要
We previously conducted a comprehensive analysis of transcription of a candidate histone methyltransferase, Setdb2, in human and mouse tissues, revealing tissue-specific expression of alternatively spliced and chimeric transcripts. We found in-frame fusion transcripts linking Setdb2 to an adjacent independent gene, Phf11, which encodes a zinc finger-containing plant homeodomain motif. We previously found several protein-binding partners for the putative histone methyltransferases using yeast two hybrid screens; most of these binding partners now have been validated by co-immunoprecipitation experiments. Further functional characterization of interactions between Setdb2 and the identified binding partners, which include an unannotated protein and other biologically interesting proteins, has been conducted. We have generated a viable, hypomorphic knockout mouse model lacking 70-80% of Setdb2 transcripts and probably most or all encoded proteins. Phenotypic characterization of these knockouts on various mouse strain backgrounds has begun. Occasional homozygous hypomorphic mice with a B cell developmental defect have been identified, suggesting they may suffer from a pre-CLL disease process. The knockout mice could comprise a new model for chronic lymphocytic leukemia, for asthma, and/or for other cancers or human diseases. Specific antibodies against mouse and human Setdb2 have been developed. We have expressed recombinant Setdb2 in baculovirus to facilitate characterization of its biochemical activities. On a preliminary basis, we have shown that Setdb2 is an active histone methyltransferase and may also methylate other cellular proteins.
我们以前进行了全面的分析,在人类和小鼠组织中的候选组蛋白甲基转移酶,Setdb 2的转录,揭示了组织特异性表达的选择性剪接和嵌合转录。我们发现框内融合转录连接Setdb 2到一个相邻的独立基因,Phf 11,它编码一个锌指含植物同源结构域基序。我们以前发现了几个蛋白质结合伙伴的假定组蛋白甲基转移酶使用酵母双杂交筛选,这些结合伙伴中的大多数现在已经通过免疫共沉淀实验验证。Setdb 2和所鉴定的结合伴侣之间的相互作用的进一步功能表征已经进行,所述结合伴侣包括未注释的蛋白质和其他生物学上感兴趣的蛋白质。我们已经产生了一个可行的,亚型敲除小鼠模型缺乏70-80%的Setdb 2转录本,可能是大多数或所有编码的蛋白质。已经开始在各种小鼠品系背景上对这些敲除进行表型表征。已经鉴定了偶尔的具有B细胞发育缺陷的纯合子低形态小鼠,表明它们可能患有前CLL疾病过程。基因敲除小鼠可以构成慢性淋巴细胞白血病、哮喘和/或其他癌症或人类疾病的新模型。已经开发了针对小鼠和人Setdb 2的特异性抗体。我们已经表达重组Setdb 2杆状病毒,以方便其生化活性的表征。在初步的基础上,我们已经表明,Setdb 2是一个活跃的组蛋白甲基转移酶,也可能甲基化其他细胞蛋白。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David Eric Symer其他文献
David Eric Symer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David Eric Symer', 18)}}的其他基金
Fluidigm BioMark HD and Juno integrated system
Fluidigm BioMark HD 和 Juno 集成系统
- 批准号:
9076066 - 财政年份:2016
- 资助金额:
$ 33.87万 - 项目类别:
PREVALENCE AND DETERMINANTS OF ORAL HPV INFECTION IN THE US POPULATION
美国人口腔 HPV 感染的患病率和决定因素
- 批准号:
9085739 - 财政年份:2012
- 资助金额:
$ 33.87万 - 项目类别:
PREVALENCE AND DETERMINANTS OF ORAL HPV INFECTION IN THE US POPULATION
美国人口腔 HPV 感染的患病率和决定因素
- 批准号:
8656982 - 财政年份:2012
- 资助金额:
$ 33.87万 - 项目类别:
Characterization of candidate histone methyltransferases
候选组蛋白甲基转移酶的表征
- 批准号:
7338646 - 财政年份:
- 资助金额:
$ 33.87万 - 项目类别:
Genomic, Transcriptional and Epigenetic Variation Due to Retrotransposition
逆转录转座引起的基因组、转录和表观遗传变异
- 批准号:
7733119 - 财政年份:
- 资助金额:
$ 33.87万 - 项目类别:
Epigenetic control of mammalian retrotransposons
哺乳动物逆转录转座子的表观遗传控制
- 批准号:
7292918 - 财政年份:
- 资助金额:
$ 33.87万 - 项目类别:
Characterization of candidate histone methyltransferases
候选组蛋白甲基转移酶的表征
- 批准号:
7965486 - 财政年份:
- 资助金额:
$ 33.87万 - 项目类别:
Genomic, Transcriptional and Epigenetic Variation Due to Retrotransposition
逆转录转座引起的基因组、转录和表观遗传变异
- 批准号:
7592810 - 财政年份:
- 资助金额:
$ 33.87万 - 项目类别:
Characterization of candidate histone methyltransferases
候选组蛋白甲基转移酶的表征
- 批准号:
7292925 - 财政年份:
- 资助金额:
$ 33.87万 - 项目类别:
相似海外基金
Defining new asthma phenotypes using high-dimensional data
使用高维数据定义新的哮喘表型
- 批准号:
2901112 - 财政年份:2024
- 资助金额:
$ 33.87万 - 项目类别:
Studentship
Basophilic oncostatin M fuels nociceptor neuron-induced asthma
嗜碱性制瘤素 M 促进伤害感受器神经元诱发哮喘
- 批准号:
485504 - 财政年份:2023
- 资助金额:
$ 33.87万 - 项目类别:
Salary Programs
Engaging Patient and Caregivers in Using Patient-reported Outcomes Measures in Pediatric Clinical Care for Asthma
让患者和护理人员参与儿科哮喘儿科临床护理中患者报告的结果测量
- 批准号:
495593 - 财政年份:2023
- 资助金额:
$ 33.87万 - 项目类别:
Air pollution and Asthma in Canada: Projections of burden and the value of climate adaptation strategies
加拿大的空气污染和哮喘:负担预测和气候适应战略的价值
- 批准号:
485322 - 财政年份:2023
- 资助金额:
$ 33.87万 - 项目类别:
Operating Grants
Data-driven model links BMIz to gene expression in pediatric asthma
数据驱动模型将 BMIz 与小儿哮喘基因表达联系起来
- 批准号:
493135 - 财政年份:2023
- 资助金额:
$ 33.87万 - 项目类别:
BIOlogic drug safety and effectiveness interNational pharmacoepidemiologIC study in pregnant women with autoimmune disorders and asthma and their children (BIONIC)
患有自身免疫性疾病和哮喘的孕妇及其子女的生物药物安全性和有效性国际药物流行病学研究(BIONIC)
- 批准号:
493526 - 财政年份:2023
- 资助金额:
$ 33.87万 - 项目类别:
Operating Grants
A Novel Approach to Target Neutrophilic Airway Inflammation and Airway Hyperresponsiveness in Therapy-Resistant (Refractory) Asthma.
一种针对难治性哮喘中性粒细胞性气道炎症和气道高反应性的新方法。
- 批准号:
10659658 - 财政年份:2023
- 资助金额:
$ 33.87万 - 项目类别:
Treating Maternal Depression in an Urban Community-Based Pediatric Asthma Clinic: Targeting Maternal Mood, Child Asthma Outcomes, and Health Disparities
在城市社区小儿哮喘诊所治疗孕产妇抑郁症:针对孕产妇情绪、儿童哮喘结果和健康差异
- 批准号:
10723233 - 财政年份:2023
- 资助金额:
$ 33.87万 - 项目类别:
Improving Prediction of Asthma-related Outcomes with Genetic Ancestry-informed Lung Function Equations
利用遗传祖先信息的肺功能方程改善哮喘相关结果的预测
- 批准号:
10723861 - 财政年份:2023
- 资助金额:
$ 33.87万 - 项目类别:
Prenatal Fatty Acid Supplementation and Early Childhood Asthma and Atopy in Black American Families
美国黑人家庭产前脂肪酸补充剂与儿童早期哮喘和特应性
- 批准号:
10586398 - 财政年份:2023
- 资助金额:
$ 33.87万 - 项目类别: